Widely used:Recently Viewed
Clear All
Today’s Range
52 Week Range
Liquidity
Market cap
$20 Mln
P/E Ratio
--
P/B Ratio
2.37
Industry P/E
90.25
Debt to Equity
0.01
ROE
-1.52 %
ROCE
--
Div. Yield
0 %
Book Value
0.3
EPS
-0.8
CFO
$-16.86 Mln
EBITDA
$-24.93 Mln
Net Profit
$-32.99 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
bioAffinity Technologies Inc (BIAF)
| -59.67 | -54.13 | -60.54 | -80.84 | -- | -- | -- |
|
BSE Sensex*
| -5.65 | -3.07 | -9.18 | 0.22 | 9.95 | 17.63 | 9.82 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2024
|
2023
|
|
|---|---|---|
|
bioAffinity Technologies Inc (BIAF)
| -37.87 | -8.09 |
|
S&P Small-Cap 600
| 7.01 | 13.89 |
|
BSE Sensex
| 8.10 | 18.74 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 16.30 | 11,098.72 | 15.67 | 12.69 | |
| 71.04 | 9,806.74 | 95.07 | 2.52 | |
| 168.21 | 9,045.60 | -- | -25.23 | |
| 272.62 | 10,288.75 | 763.23 | 1.2 |
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung. It offers CyPath lung, a diagnostic test, for early detection of lung cancer. The company was incorporated... in 2014 and is based in San Antonio, Texas. Address: 22211 West Interstate 10, San Antonio, TX, United States, 78257 Read more
Founder & Executive Chairman of the Board
Mr. Steven Girgenti
Founder & Executive Chairman of the Board
Mr. Steven Girgenti
Headquarters
San Antonio, TX
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of bioAffinity Technologies Inc (BIAF) stood at $ 9 Mln as on 30-Sep-24
The share price of bioAffinity Technologies Inc (BIAF) is $0.37 (NASDAQ) as of 14-Mar-2025 16:00 EDT. bioAffinity Technologies Inc (BIAF) has given a return of -80.84% in the last 1 years.
bioAffinity Technologies Inc (BIAF) has a market capitalisation of $ 20 Mln as on 13-Mar-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of bioAffinity Technologies Inc (BIAF) is 2.37 times as on 13-Mar-2025, a 36% discount to its peers’ median range of 3.72 times.
Since, TTM earnings of bioAffinity Technologies Inc (BIAF) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the bioAffinity Technologies Inc (BIAF) and enter the required number of quantities and click on buy to purchase the shares of bioAffinity Technologies Inc (BIAF).
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung. It offers CyPath lung, a diagnostic test, for early detection of lung cancer. The company was incorporated in 2014 and is based in San Antonio, Texas. Address: 22211 West Interstate 10, San Antonio, TX, United States, 78257
The CEO & director of Mr. Steven Girgenti. is bioAffinity Technologies Inc (BIAF), and CFO & Sr. VP is Mr. Steven Girgenti.
There is no promoter pledging in bioAffinity Technologies Inc (BIAF).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,103
|
|
|
1,084
|
|
|
1,055
|
|
|
990
|
| bioAffinity Technologies Inc. (BIAF) | Ratios |
|---|---|
|
Return on equity(%)
|
-201.62
|
|
Operating margin(%)
|
-63.96
|
|
Net Margin(%)
|
-90.16
|
|
Dividend yield(%)
|
0
|
No, TTM profit after tax of bioAffinity Technologies Inc (BIAF) was $0 Mln.
$0.01
(
